Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

FDA Approves Extended Shelf Life for CSL Behring’s Hizentra

By Pharmaceutical Processing | February 24, 2011

CSL Behring announced today that the FDA has approved a
supplemental Biologics License Application (sBLA) to extend the shelf life of
Hizentra(R), Immune Globulin Subcutaneous (Human), 20% Liquid, from 24 months
to 30 months. Hizentra, the first and only 20 percent subcutaneous
immunoglobulin (SCIg) approved in the U.S.,
is the only SCIg in the U.S.
that can be stored at room temperature throughout its entire shelf life.

Hizentra is indicated for the treatment of primary humoral immunodeficiency
(PI). PI is a group of disorders, usually genetic, that result from a
dysfunctional immune system. This condition prevents patients from fighting off
infections caused by common germs.

“Based on what we know patients and their healthcare
providers need and want, CSL Behring continually strives to enhance the
products in our extensive portfolio,” said Lynne Powell, CSL Behring
Senior Vice President, North America
Commercial Operations. “The ability to store Hizentra without
refrigeration for up to two and a half years is a milestone that provides added
convenience to busy and active patients, while serving as another example of
CSL Behring’s dedication to meeting customer needs.” Stabilized with
L-proline, a naturally occurring amino acid, Hizentra can be stored at room
temperature (up to 25 C 77 F) for up to 30 months. Because no refrigeration is
necessary, Hizentra is always ready to use without warming, offering patients
and physicians convenience and portability.

“Since transitioning to Hizentra, I havethe freedom to
choose the time of day and in what setting I self-infuse my therapy,” said
Hizentra patient Jean Stefanic. “The convenience this product offers fits
my busy schedule and helps me lead a normal life.” The sBLA for Hizentra
was based on a study assessing the product’s stability for 30 months.
Physicochemical, biological and immunological parameters were assessed under
controlled conditions at 25 C (77 F).

The data generated from this study demonstrated that when
Hizentra is stored at room temperature (up to 25C 77F) and protected from light,
it is stable for up to 30 months.

Hizentra with 30-month shelf life packaging is expected to
be available later this year. Current Hizentra patients are encouraged to contact
their physician with any questions regarding the shelf life of their current
supply.

 

Related Articles Read More >

FDA logo
Ultra Supplement announces recall for undeclared tadalafil
analyzing medical sample
Expert answers to nitrosamine impurity questions
Cardinal Health
Cardinal Health announces $124M settlement of investors’ opioid suit
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards